Management of Patients with Interstitial Lung Disease in the Midst of the COVID-19 Pandemic
Author:
Publisher
S. Karger AG
Subject
Pulmonary and Respiratory Medicine
Reference10 articles.
1. Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al.; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018 Sep;198(5):e44–68.
2. Halpin DM, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020 May;8(5):436–8.
3. Ceribelli A, Motta F, De Santis M, Ansari AA, Ridgway WM, Gershwin ME, et al. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy. J Autoimmun. 2020 May;109:102442.
4. Kreuter M, Polke M, Walsh SL, Krisam J, Collard HR, Chaudhuri N, et al. Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation. Eur Respir J. 2020 Apr;55(4):1901760.
5. Collins SL, Chan-Li Y, Oh M, Vigeland CL, Limjunyawong N, Mitzner W, et al. Vaccinia vaccine-based immunotherapy arrests and reverses established pulmonary fibrosis. JCI Insight. 2016 Apr;1(4):e83116.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. COVID-19 in patients with interstitial lung disease;COVID-19: An Update;2024-09-01
2. Gradually Progressive Interstitial Pneumonia Following COVID-19 in an Older Patient: A Case Report;Cureus;2023-12-01
3. Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications;Inflammopharmacology;2022-05-30
4. SARS‑CoV‑2 infection and children: Insights from the 6th Workshop on Paediatric Virology (Review);World Academy of Sciences Journal;2022-03-10
5. The experience of people with idiopathic pulmonary fibrosis living through the COVID‐19 pandemic;Journal of Advanced Nursing;2022-02-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3